Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

The CDC first recommended annual flu shots for all children 6 months and older in 2008, when it expanded the recommendation ...

The Institute for the Advancement of Food & Nutrition Science publishes a list of general principles it hopes will inform any ...

As another new year gets under way many of us will be looking for a way of boosting how we feel but is it better to hit the ...

The press release promoting the study asserts that “universal SEL programs are a sound investment in education systems ...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...